News

Opposition attacks Centre for lifiting ban on export of drugs

Our Bureau New Delhi | Updated on April 07, 2020 Published on April 07, 2020

Rahul Gandhi

The Opposition parties have criticised the Centre's decision to resume of export of hydroxychloroquine and other drugs after US President Donald Trump warned of retaliation. The parties said the Centre has let down the people of the country.

"Friendship isn’t about retaliation. India must help all nations in their hour of need but lifesaving medicines should be made available to Indians in ample quantities first," said former Congress president Rahul Gandhi.

CPI(M) general secretary Sitaram Yechury said: "The statement by US President is unacceptable. But Modi government has succumbed to the threat by allowing the export. That this happened after an expensive gala was organised for him by Modi, instead of preparing to contain Covid-19, shows how this govt has let down India," said

"India’s priority must be treatment of Indians in this battle against Covid. By succumbing to Trump’s pressures and threats, Modi cannot be allowed to risk shortages of crucial drugs here. There are no compromises in this struggle to protect Indian lives,” he added.

Congress MP Shashi Tharoor, also a former under Secretary General of the United Nations, said in post on Twitter: "Never in my decades of experience in world affairs have I heard a Head of State or Govt openly threatening another like this. What makes Indian hydroxychloroquine 'our supply’, Mr President? It only becomes your supply when India decides to sell it to you."

Published on April 07, 2020

A letter from the Editor


Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
This article is closed for comments.
Please Email the Editor
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.